Domain 1: Prevention Key Performance Indicators
Prevention KPIs: The impact of prescribing patterns 2 Confidential property of Optum. Do not distribute or reproduce without express permission from Optum.
Measuring compliance with the CDC prescribing guidelines (2016) OUTCOME MEASURE PROCESS MEASURES 99.6% Initial opioid prescription is for short acting formulation 77.2% Initial opioid prescription is for <50MME/day 55.4% 79.7% Initial opioid prescription is for <=7 days supply Initial opioid prescription 78.0% compliant with CDC No concurrent opioid recommendations and benzodiazepine use 100% Initial prescription is not for methadone 3 Confidential property of Optum. Do not distribute or reproduce without express permission from Optum.
North Carolina: Initial opioid Rx is compliant with CDC recommendations, by county, 2016 (blue = better performance) 4
North Carolina: Initial opioid Rx is for < 50 MME/day, by county, 2016 (blue = better performance) 5
North Carolina: Initial opioid Rx is for < 7 days’ supply, by county, 2016 (blue = better performance) 6
Additional prescribing indicators (2016) OUTCOME MEASURES PROCESS MEASURES No use of opioids for New opioid fillers per 1,000 87.1% 122 new low back pain enrollees patients 97.9% New opioid fillers who No concurrent opioid avoid chronic use and benzodiazepine 78.0% use Prevalence of opioid 35.9 overdose (OD) per 100,000 Appropriate contact person-years with provider before 54.0% second opioid prescription 7 Confidential property of Optum. Do not distribute or reproduce without express permission from Optum.
Prescribing Guideline Dissemination & Implementation Approach Clinician Translation & Education & Communication Training Health Systems Insurer Interventions Interventions
Recommend
More recommend